摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 4-[4-[4-(bis(4-methylphenyl)hydroxymethyl)-1-piperidinyl]-1-oxobutyl]-α, α-dimethylphenylacetate | 162096-58-4

中文名称
——
中文别名
——
英文名称
methyl 4-[4-[4-(bis(4-methylphenyl)hydroxymethyl)-1-piperidinyl]-1-oxobutyl]-α, α-dimethylphenylacetate
英文别名
Methyl 4-[4-[4-(bis(4-methylphenyl) hydroxymethyl)-1-piperidinyl]-1-oxobutyl]-alpha,alpha-dimethylphenylacetate;methyl 2-[4-[4-[4-[hydroxy-bis(4-methylphenyl)methyl]piperidin-1-yl]butanoyl]phenyl]-2-methylpropanoate
methyl 4-[4-[4-(bis(4-methylphenyl)hydroxymethyl)-1-piperidinyl]-1-oxobutyl]-α, α-dimethylphenylacetate化学式
CAS
162096-58-4
化学式
C35H43NO4
mdl
——
分子量
541.731
InChiKey
RSFYLBVXPMDBIF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    679.7±55.0 °C(predicted)
  • 密度:
    1.113±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.5
  • 重原子数:
    40
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    66.8
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Piperidine derivatives
    申请人:Albany Molecular Research, Inc.
    公开号:US05578610A1
    公开(公告)日:1996-11-26
    The present invention relates to substantially pure piperidine derivative compounds of the formulae: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; R.sub.3 is --COOH or --COOR.sub.4 ; R.sub.4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.
    本发明涉及公式为:##STR1##的基本纯品吡啶衍生物化合物。其中,R.sub.1是氢或羟基; R.sub.2是氢; 或R.sub.1和R.sub.2在一起形成连接R.sub.1和R.sub.2的碳原子之间的第二个键; R.sub.3是--COOH或--COOR.sub.4; R.sub.4具有1到6个碳原子; A、B和D是它们各自环的取代基,每个环可能不同或相同,是氢、卤素、烷基、羟基、烷氧基或其他取代基。本发明还公开了制备这种基本纯品吡啶衍生物化合物的方法。
  • [EN] PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION<br/>[FR] DERIVES DE PIPERIDINE ET PROCEDES DE PRODUCTION DE CES DERIVES
    申请人:ALBANY MOLECULAR RESEARCH, INC.
    公开号:WO1995000482A1
    公开(公告)日:1995-01-05
    (EN) The present invention relates to substantially pure piperidine derivative compounds of formulae (I) or (II) wherein R1 is hydrogen or hydroxy; R2 is hydrogen; or R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2; R3 is -COOH or -COOR4; R4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.(FR) L'invention se rapporte à des composés dérivés de la pipéridine pratiquement purs, de formules (I) ou (II), dans lesquelles: R1 est hydrogène ou hydroxy; R2 est hydrogène; ou bien R1 et R2 pris ensemble forment une seconde liaison entre les atomes de carbone portant R1 et R2; R3 est -COOH ou -COOR4; R4 a 1 à 6 atomes de carbone; A, B et D sont les substituants de leurs chaînes respectives, chacun pouvant être différent ou identique, et sont hydrogène, halogène, alcoyle, hydroxy, alcoxy, ou d'autres substituants. L'invention se rapporte également au procédé de préparation de tels composés dérivés de la pipéridine sous forme pratiquement pure.
    本发明涉及公式(I)或(II)的实质纯的哌啶生物化合物,其中R1为氢或羟基;R2为氢;或者R1和R2一起形成连接R1和R2所在碳原子的第二个键;R3为-COOH或-COOR4;R4具有1至6个碳原子;A、B和D是它们各自环的取代基,每个取代基可以不同或相同,并且是氢、卤素、烷基、羟基、烷氧基或其他取代基。本发明还公开了制备这种实质纯的哌啶生物化合物的方法。
  • Piperidine derivatives and process for their production
    申请人:——
    公开号:US20030018196A1
    公开(公告)日:2003-01-23
    The present invention relates to substantially pure piperidine derivative compounds of the formulae: 1 wherein R 1 is hydrogen or hydroxy; R 2 is hydrogen; or R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 ; R 3 is —COOH or —COOR 4 ; R 4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.
    本发明涉及公式1的基本纯的哌啶生物化合物: 其中,R1为氢或羟基;R2为氢;或R1和R2共同形成连接R1和R2的碳原子之间的第二个键;R3为—COOH或—COOR4;R4具有1至6个碳原子;A、B和D是它们各自环的取代基,每个取代基可以不同或相同,且为氢、卤素、烷基、羟基、烷氧基或其他取代基。 本发明还公开了制备这种基本纯的哌啶生物化合物的方法。
  • PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
    申请人:D'Ambra Thomas E.
    公开号:US20080227983A1
    公开(公告)日:2008-09-18
    The present invention relates to substantially pure piperidine derivative compounds of the formulae: wherein R 1 is hydrogen or hydroxy; R 2 is hydrogen; or R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 ; R 3 is —COOH or —COOR 4 ; R 4 has 1 to 6 carbon atoms; A, B, and D are the substituents of their respective rings, each of which may be different or the same and are hydrogen, halogens, alkyl, hydroxy, alkoxy, or other substituents. A process of preparing such piperidine derivative compounds in substantially pure form is also disclosed.
    本发明涉及下列式的基本纯度吡啶衍生物化合物: 其中, R1是氢或羟基; R2是氢;或者R1和R2结合形成连接R1和R2的碳原子之间的第二键; R3是—COOH或—COOR4; R4具有1至6个碳原子; A、B和D是它们各自环的取代基,每个取代基可以不同,也可以相同,是氢、卤素、烷基、羟基、烷氧基或其他取代基。 本发明还公开了制备这种基本纯度吡啶衍生物化合物的方法。
  • PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES
    申请人:D'AMBRA Thomas E.
    公开号:US20100010227A1
    公开(公告)日:2010-01-14
    The present invention discloses a process for preparing the piperidine derivative compound 4-[4-[4-hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetic acid of formula comprising the sequential steps of: (1) reacting 4-bromo-α,α-dimethyl-α-(4,4-dimethylisoxazolin-2-yl)toluene with 4-chlorobutyryl chloride to provide 4-(4-chloro-1-oxobutyl)-α,α-dimethyl-α-(4,4-dimethylisoxazolin-2-yl)toluene; (2) hydrolyzing said 4-(4-chloro-1-oxobutyl)-α,α-dimethyl-α-(4,4-dimethylisoxazolin-2-yl)toluene to provide 4-(4-chloro-1-oxobutyl)-α,α-dimethylphenylacetic acid; (3) reacting said 4-(4-chloro-1-oxobutyl)-α,α-dimethylphenylacetic acid with methanol to provide methyl 4-(4-chloro-1-oxobutyl)-α,α-dimethylphenylacetate; (4) reacting said methyl 4-(4-chloro-1-oxobutyl)-α,α-dimethylphenylacetate with 4-(α,α-diphenyl)piperidinemethanol to provide methyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α-dimethylphenylacetate; (5) reducing said methyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-oxobutyl]-α,α-dimethylphenylacetate to provide methyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetate; and (6) hydrolyzing said methyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetate to provide said 4-[4-[4-hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetic acid.
    本发明揭示了一种制备式为4-[4-[4-羟基二苯甲基)-1-哌啶基]-1-羟基丁基]-α,α-二甲基苯乙酸哌啶生物化合物的方法,包括以下步骤:(1)将4--α,α-二甲基-α-(4,4-二甲基异恶唑-2-基)甲苯4-氯丁酰氯反应,得到4-(4--1-氧代丁基)-α,α-二甲基-α-(4,4-二甲基异恶唑-2-基)甲苯;(2)解所述的4-(4--1-氧代丁基)-α,α-二甲基-α-(4,4-二甲基异恶唑-2-基)甲苯,得到4-(4--1-氧代丁基)-α,α-二甲基苯乙酸;(3)将所述的4-(4--1-氧代丁基)-α,α-二甲基苯乙酸甲醇反应,得到甲基4-(4--1-氧代丁基)-α,α-二甲基苯乙酸酯;(4)将所述的甲基4-(4--1-氧代丁基)-α,α-二甲基苯乙酸酯与4-(α,α-二苯基)哌啶甲醇反应,得到甲基4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-氧代丁基]-α,α-二甲基苯乙酸酯;(5)将所述的甲基4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-氧代丁基]-α,α-二甲基苯乙酸酯还原,得到甲基4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-羟基丁基]-α,α-二甲基苯乙酸酯;(6)解所述的甲基4-[4-[4-(羟基二苯甲基)-1-哌啶基]-1-羟基丁基]-α,α-二甲基苯乙酸酯,得到所述的4-[4-[4-羟基二苯甲基)-1-哌啶基]-1-羟基丁基]-α,α-二甲基苯乙酸
查看更多

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (1aR,4E,7aS,8R,10aS,10bS)-8-[((二甲基氨基)甲基]-2,3,6,7,7a,8,10a,10b-八氢-1a,5-二甲基-氧杂壬酸[9,10]环癸[1,2-b]呋喃-9(1aH)-酮 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸溴乙酯 齐墩果酸二甲胺基乙酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 齐墩果-12-烯-28-酸,3,7-二羰基-(9CI) 齐墩果-12-烯-28-酸,3,21,29-三羟基-,g-内酯,(3b,20b,21b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸